StockData
Arcturus Therapeutics Holdings Inc. logo

Arcturus Therapeutics Holdings Inc. (ARCT) stock

ARCTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/3010% below fair value
$8.04+0.07 (+0.88%)

Close on Nov 18, 2026Market cap $228.52MP/E –Yield –

Arcturus Therapeutics total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Arcturus Therapeutics's total debt was $15.00M at Mar 31, 2025. For fiscal 2022 it was $60.66M, down 3.9% from the year before. The highest annual figure on record is $63.11M in fiscal 2021.

Annual total debt

PeriodPeriod endValueChange
FY2022Dec 31, 2022$60.66M-3.9%
FY2021Dec 31, 2021$63.11M+318.1%
FY2020Dec 31, 2020$15.10M+0.7%
FY2019Dec 31, 2019$15.00M+51.3%
FY2018Dec 31, 2018$9.91M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q1 FY2025Mar 31, 2025$15.00M-76.1%
Q3 FY2023Sep 30, 2023$20.00M-68.5%
Q4 FY2022Dec 31, 2022$60.66M-3.9%
Q3 FY2022Sep 30, 2022$59.74M-1.8%
Q2 FY2022Jun 30, 2022$62.78M+2.4%
Q1 FY2022Mar 31, 2022$63.50M+3.6%
Q4 FY2021Dec 31, 2021$63.11M+318.1%
Q3 FY2021Sep 30, 2021$60.83M+303.5%
Q2 FY2021Jun 30, 2021$61.31M+307.1%
Q1 FY2021Mar 31, 2021$61.27M+307.7%
Q4 FY2020Dec 31, 2020$15.10M+0.7%
Q3 FY2020Sep 30, 2020$15.08M+50.5%
Q2 FY2020Jun 30, 2020$15.06M+50.9%
Q1 FY2020Mar 31, 2020$15.03M+51.6%
Q4 FY2019Dec 31, 2019$15.00M–
Q3 FY2019Sep 30, 2019$10.02M–
Q2 FY2019Jun 30, 2019$9.98M–
Q4 FY2018Dec 31, 2018$9.91M–

More Arcturus Therapeutics figures

See a number that looks wrong?